Coral Labs.

26
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE683E01017
  • NSEID:
  • BSEID: 524506
INR
451.00
-4 (-0.88%)
BSENSE

Dec 19

BSE+NSE Vol: 684

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 37.47% vs 7.09% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 61.58% vs 326.03% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 48,700.00% vs -99.94% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 52.99% vs 144.97% in Mar 2024

Compare Profit and Loss Results of Coral Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
115.00
112.00
3.00
2.68%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
115.00
112.00
3.00
2.68%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-1.00
4.00
400.00%
Raw Materials Consumed
49.00
71.00
-22.00
-30.99%
Power & Fuel Cost
3.00
2.00
1.00
50.00%
Employee Cost
14.00
14.00
0.00
0.00%
Operating Expenses
4.00
3.00
1.00
33.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
8.00
-6.00
-75.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
5.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
88.00
107.00
-19.00
-17.76%
Operating Profit (PBDIT) excl Other Income
26.00
5.00
21.00
420.00%
Other Income
9.00
23.00
-14.00
-60.87%
Operating Profit (PBDIT)
35.00
28.00
7.00
25.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
35.00
28.00
7.00
25.00%
Depreciation
2.00
2.00
0.00
0.00%
Profit Before Taxation & Exceptional Items
33.00
25.00
8.00
32.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
32.00
25.00
7.00
28.00%
Provision for Tax
8.00
6.00
2.00
33.33%
Profit After Tax
24.00
19.00
5.00
26.32%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
147.00
85.00
62.00
72.94%
Profit Available for appropriations
171.00
105.00
66.00
62.86%
Appropriations
171.00
105.00
66.00
62.86%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
67.61
9.42
58.19
617.73%
Profit And Loss - Net Sales
Net Sales 115.01 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 37.47% vs 7.09% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 61.58% vs 326.03% in Mar 2024

Profit And Loss - Interest
Interest 0.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 48,700.00% vs -99.94% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 24.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 52.99% vs 144.97% in Mar 2024